24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid and dependable dividends. These five make sense for growth and income investors.
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex,…
Jon C. Ogg AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.
Chris Lange The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and Ferrari.
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Broadcom, Dow, Lyft, Netflix, Roku, Walt Disney, Wingstop and Xilinx.
The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, CarMax, Celgene, Chevron, Exxon Mobil, Lyft, FedEx, Peabody Energy, UPS and Wells Fargo.
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
The top analyst upgrades, downgrades and initiations seen on Friday included Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software and Valero Energy.
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron and Tesla.
Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see…
The include top analyst upgrades, downgrades and initiations seen from Thursday AVEO Pharmaceuticals, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon Athletica, Macy's, Sysco and Teladoc Health.
These five top growth companies are all rated Buy and pay outstanding dividends, and they have good growth prospects.
Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.
